ROSENBERGER BRIAN (VP, Commercial) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/28/2022ACC: 0001062993-22-001782
Officer· VP, Commercial
Since Jan 2019
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+60K
Price / share
—
Trade value
—
% of position
162.2%
1/26/2022
37K→97K
Total
Net shares
+60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2022 | A · Award | +60K | — | — | 162.2% | 37K | 97K |
| Total | +60K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
90K shares
Shares
+90K
Strike price
2.41
Held after
90K
Exercisable
—
1/26/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock90K shares | 1/26/2022 | A · Award | +90K | 2.41 | — | 90K |